Clinical Trials - ESLA

NCT ID	Title	Status	Phases	Start Date	Completion Date	Primary Completion Date
NCT06343311	T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)	RECRUITING	PHASE1, PHASE2	2024-06-01	2027-12-31	2026-12-31